At Vitality Integrative Medicine , we offer evidence-based GLP-1 therapies including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) as part of a comprehensive, integrative approach to weight loss and overall wellness
In pancreatic -cells, this results in enhanced glucose-dependent insulin exocytosis the incretin effect and also drives insulin gene expression and -cell survival and proliferation via the PI3K/Akt pathway
In 2020, Saxenda was approved for children and adolescents 12 years and older with obesity or overweight with an associated health problem, such as high blood pressure
More serious risks include pancreatitis, gallbladder disease, acute kidney injury (particularly with dehydration), hypoglycemia (when combined with insulin or sulfonylureas), and thyroid C-cell tumors in animal studies
Theoretical Benefits: Weight Loss and Inflammation GLP-1 agonists are primarily approved for weight loss and diabetes management
(Pricing is dependent on dose and paid to Lilly Directly) The Zepbound medication is delivered to your home by Lilly Direct Pharmacy